We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
-32.84%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$12.3M
AUM Growth
+$4.95M
Cap. Flow
+$7.65M
Cap. Flow %
62.07%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPID icon
Rapid Micro Biosystems
RPID
+$7.65M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPID icon
1
Rapid Micro Biosystems
RPID
$86.7M
$7.05M 57.23%
+1,038,296
New +$7.65M
MDVL
2
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$3.77M 30.64%
77,719
– –
LUNG icon
3
Pulmonx
LUNG
$99.2M
$1.49M 12.13%
60,204
– –

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, ABG-WTT Global Life Science Capital Partners held 3 positions worth $12.3M, up 67% from $7.37M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG-WTT Global Life Science Capital Partners deployed $7.65M of net new capital in Q1 2022, opening 1 new position. Its largest new stake was Rapid Micro Biosystems: 1,038,296 shares worth $7.05M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners's largest Q1 2022 buy was Rapid Micro Biosystems: 1,038,296 shares worth $7.05M.
  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $12.3M portfolio in Q1 2022.
  • ABG-WTT Global Life Science Capital Partners opened 1 new position and closed 0 in Q1 2022.
  • ABG-WTT Global Life Science Capital Partners's portfolio value rose 67% quarter-over-quarter to $12.3M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.